Skip to main content

ETF Objective

The Fund seeks results that correspond to the long-term sector of the U.S. Treasury market as defined by the Barclays Capital 10-20 Year U.S. Treasury Index. The Index measures the performance of public obligations of the U.S. Treasury that have a remaining maturity of greater than 10 years and less than 20 years.

Stock Chart

as of 4:10 PM ET 11/29/2021

Performance

  • 1 Week
  • +1.29%
  • 1 Month
  • +0.73%
  • 3 Months
  • -1.66%
  • 1 Yr Return
  • -8.94%
  • 5 Yr Return
  • +10.32%

Sector Breakdown

Government/AAA 100.00%

Geographic Exposure



No Geographic Exposure Data For Symbol

Top 10 Holdings



No Top 10 Holdings Information

ETF Overview

Sponsor BlackRock
iNav Ticker BTKY
Inception Date 01/05/2007
Name iShares:10-20 Trs Bd ETF
CUSIP 464288653
Prospectus Date 06/29/2021

ETF Characteristics

Market Capitalization n/a
Total Net Assets 1.52 K
Management Fee 0.15%
Administration Fee 0.00%
Asset Class Fixed Income
Sub Asset Class General U.S. Treasury Funds
Number Of Holdings n/a
Expense Ratio 0.15
Dividend 1.60
Dividend Frequency Monthly

LATEST NEWS

Recent Articles from TheStreet

Facebook Meta Logo Lead

Facebook Owner Meta told by U.K. Antitrust Regulator to Sell Giphy

Facebook parent Meta has been order by the U.K.’s competition watchdog to sell GIF-sharing platform Giphy, which it bought in 2020 for a reported $400 million.

Immunogen Tanks After Ovarian Cancer Drug Study Fails to Meet Endpoint

ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial

ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.

Semiconductor Lead

Lam Research and KLA: 2 Must-Own Chip-Equipment Stocks

Amid the chip shortage, two key equipment stocks fly under the radar: Lam Research and KLA.

Merck Lead

Merck Covid-19 Pill to Be Reviewed by FDA Advisory Panel

Merck’s Covid-19 oral antiviral pill will be reviewed by an outside panel of advisors to the FDA on Tuesday, paving the way for potential authorization by year-end.

Moderna vaccine Lead

Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings

Moderna said its Covid vaccine would likely experience a 'material drop' in efficacy against Omicron, while Regeneron warned its antibody cocktail may also have reduced activity against the new variant.

Wall Street Lead

Moderna Warns on Omicron, Powell, Yellen Face Senate - 5 Things You Must Know

Stocks slump as Omicron concerns resurface; Moderna CEO cautions on vaccine efficacy against new variant; Powell and Yellen to testify before the Senate Banking Committee on CARES Act; FTC orders supply chain probe and cloud adoption software group HashiCorp seeks $13 billion valuation in upcoming Nasdaq IPO.

Wall Street Lead

Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix

Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.

Lululemon Clothes Retail Lead

Lululemon Files Patent Lawsuit Against Peloton

Lululemon seeks injunction in leggings and sports bra design dispute with Peloton.

Jack Dorsey Lead

Jack Dorsey's Net Worth After Twitter Farewell

Twitter's departing CEO has maintained a detached view of his wealth and has donated a lot of it.